Huatai Securities released a report on China's medical aesthetics industry, highlighting a 'medical aesthetics equality' era driven by upstream product expansion, midstream platform education, and downstream consolidation.
The medical aesthetics industry is undergoing a transformation, with upstream innovation and downstream consolidation offering investment opportunities.
Free preview — more China A-share & HK research · About Us · Legal & Privacy